Allianz Asset Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $158M | Sell |
1,968,211
-224,059
| -10% | -$18.5M | 0.17% | 118 |
|
|
2025
Q4 | $187M | Buy |
2,192,270
+443,285
| +25% | +$36.4M | 0.19% | 93 |
|
|
2025
Q3 | $136M | Buy |
1,748,985
+998,853
| +133% | +$78M | 0.15% | 126 |
|
|
2025
Q2 | $58.7M | Buy |
750,132
+290,048
| +63% | +$21.6M | 0.07% | 277 |
|
|
2025
Q1 | $33.3M | Buy |
460,084
+6,436
| +1% | +$461K | 0.04% | 416 |
|
|
2024
Q4 | $33.6M | Sell |
453,648
-60,073
| -12% | -$4.2M | 0.04% | 404 |
|
|
2024
Q3 | $33.9M | Buy |
513,721
+42,404
| +9% | +$3.08M | 0.05% | 383 |
|
|
2024
Q2 | $43.5M | Sell |
471,317
-66,357
| -12% | -$5.88M | 0.06% | 298 |
|
|
2024
Q1 | $51.4M | Sell |
537,674
-215,901
| -29% | -$18.1M | 0.08% | 254 |
|
|
2023
Q4 | $57.5M | Sell |
753,575
-271,516
| -26% | -$18.9M | 0.09% | 213 |
|
|
2023
Q3 | $71M | Sell |
1,025,091
-204,237
| -17% | -$16.4M | 0.12% | 184 |
|
|
2023
Q2 | $116M | Sell |
1,229,328
-8,441
| -0.7% | -$734K | 0.21% | 102 |
|
|
2023
Q1 | $102M | Sell |
1,237,769
-40,208
| -3% | -$3.16M | 0.18% | 110 |
|
|
2022
Q4 | $95.3M | Buy |
1,277,977
+31,308
| +3% | +$2.41M | 0.19% | 115 |
|
|
2022
Q3 | $103M | Sell |
1,246,669
-113,986
| -8% | -$11M | 0.21% | 98 |
|
|
2022
Q2 | $129M | Buy |
1,360,655
+214,039
| +19% | +$22.2M | 0.12% | 181 |
|
|
2022
Q1 | $135M | Sell |
1,146,616
-330,250
| -22% | -$37M | 0.1% | 215 |
|
|
2021
Q4 | $191M | Buy |
1,476,866
+31,676
| +2% | +$3.69M | 0.13% | 172 |
|
|
2021
Q3 | $164M | Buy |
1,445,190
+529,784
| +58% | +$60.5M | 0.13% | 172 |
|
|
2021
Q2 | $94.8M | Buy |
915,406
+111,990
| +14% | +$10.6M | 0.08% | 243 |
|
|
2021
Q1 | $67.2M | Sell |
803,416
-226,020
| -22% | -$19.1M | 0.07% | 294 |
|
|
2020
Q4 | $93.9M | Buy |
1,029,436
+294,332
| +40% | +$24.4M | 0.09% | 216 |
|
|
2020
Q3 | $58.7M | Sell |
735,104
-57,081
| -7% | -$4.45M | 0.07% | 294 |
|
|
2020
Q2 | $54.7M | Sell |
792,185
-24,349
| -3% | -$1.73M | 0.06% | 319 |
|
|
2020
Q1 | $51.3M | Buy |
816,534
+258,933
| +46% | +$18.7M | 0.07% | 305 |
|
|
2019
Q4 | $43.4M | Buy |
557,601
+179,886
| +48% | +$14M | 0.04% | 480 |
|
|
2019
Q3 | $27.7M | Buy |
377,715
+28,512
| +8% | +$2M | 0.03% | 645 |
|
|
2019
Q2 | $21.5M | Sell |
349,203
-104,436
| -23% | -$6.32M | 0.02% | 780 |
|
|
2019
Q1 | $28.9M | Sell |
453,639
-16,953
| -4% | -$967K | 0.03% | 610 |
|
|
2018
Q4 | $24M | Buy |
470,592
+10,311
| +2% | +$522K | 0.03% | 620 |
|
|
2018
Q3 | $26.7M | Sell |
460,281
-35,946
| -7% | -$1.76M | 0.02% | 726 |
|
|
2018
Q2 | $24.1M | Buy |
496,227
+108,111
| +28% | +$5.05M | 0.02% | 773 |
|
|
2018
Q1 | $18.1M | Buy |
388,116
+258,696
| +200% | +$11.2M | 0.02% | 943 |
|
|
2017
Q4 | $4.86M | Sell |
129,420
-1,363,911
| -91% | -$50.1M | ﹤0.01% | 1636 |
|
|
2017
Q3 | $54.4M | Sell |
1,493,331
-369,177
| -20% | -$14.1M | 0.05% | 473 |
|
|
2017
Q2 | $73.4M | Sell |
1,862,508
-172,575
| -8% | -$6.3M | 0.07% | 334 |
|
|
2017
Q1 | $63.8M | Sell |
2,035,083
-870,771
| -30% | -$27.3M | 0.06% | 387 |
|
|
2016
Q4 | $90.8M | Buy |
2,905,854
+336,018
| +13% | +$10.9M | 0.08% | 304 |
|
|
2016
Q3 | $103M | Sell |
2,569,836
-67,392
| -3% | -$2.54M | 0.1% | 215 |
|
|
2016
Q2 | $87.7M | Sell |
2,637,228
-315,900
| -11% | -$10.8M | 0.09% | 239 |
|
|
2016
Q1 | $86.8M | Buy |
2,953,128
+2,347,122
| +387% | +$64.8M | 0.1% | 200 |
|
|
2015
Q4 | $16M | Sell |
606,006
-77,352
| -11% | -$2.01M | 0.02% | 859 |
|
|
2015
Q3 | $16.2M | Buy |
683,358
+32,916
| +5% | +$794K | 0.02% | 793 |
|
|
2015
Q2 | $15.4M | Buy |
650,442
+490,140
| +306% | +$11.1M | 0.02% | 905 |
|
|
2015
Q1 | $3.81M | Buy |
160,302
+56,220
| +54% | +$1.26M | ﹤0.01% | 1326 |
|
|
2014
Q4 | $2.21M | Buy |
104,082
+24
| +0% | +$482 | ﹤0.01% | 1512 |
|
|
2014
Q3 | $1.77M | Buy |
104,058
+17,310
| +20% | +$273K | ﹤0.01% | 1477 |
|
|
2014
Q2 | $1.24M | Sell |
86,748
-2,448,738
| -97% | -$33.2M | ﹤0.01% | 1336 |
|
|
2014
Q1 | $31.3M | Sell |
2,535,486
-1,218,636
| -32% | -$14.1M | 0.04% | 442 |
|
|
2013
Q4 | $41.1M | Buy |
3,754,122
+2,413,212
| +180% | +$27.2M | 0.05% | 376 |
|
|
2013
Q3 | $15.6M | Buy |
1,340,910
+63,510
| +5% | +$743K | 0.02% | 564 |
|
|
2013
Q2 | $14.3M | Buy |
+1,277,400
| New | +$15.1M | 0.02% | 557 |
|
Other funds holding EW
VCM
VPM
Allianz Asset Management's EW Position: Q1 2026 in Review
Allianz Asset Management reduced its Edwards Lifesciences (EW) stake by 10% in Q1 2026, selling an estimated $18.5M and leaving 1,968,211 shares worth $158M. The position accounts for 0.17% of the portfolio, ranked #118.
Allianz Asset Management first reported a position in EW in Q2 2013 and has held it in 52 quarters since. The position peaked at $191M in Q4 2021. 1,284 funds tracked by Wall St. Rank hold EW as of Q1 2026.
- Allianz Asset Management held 1,968,211 shares of Edwards Lifesciences worth $158M as of Q1 2026.
- Allianz Asset Management sold 224,059 Edwards Lifesciences shares in Q1 2026, an estimated $18.5M.
- Edwards Lifesciences made up 0.17% of Allianz Asset Management's portfolio in Q1 2026, its #118 holding.
- Allianz Asset Management first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 52 quarters since.
- Allianz Asset Management's Edwards Lifesciences position peaked at $191M in Q4 2021.
- 1,284 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.
Based on Allianz Asset Management's 13F filing for Q1 2026, filed 11 May 2026.